An insight into advances and challenges in the development of potential stearoyl Co-A desaturase 1 inhibitors

Abstract

SCD1 inhibitors block the conversion of saturated to monounsaturated fatty acids, reducing lipid accumulation, desaturation index, fat mass, and lipotoxicity. They are promising for treating various metabolic disorders.